Array Technologies Inc
(NASDAQ: ARRY)

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

7.660 -

-0.200 (-2.54%)
Range 7.585 - 8.145   (7.38%)
Open 7.910
Previous Close 7.860
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 7,415,328
Value 44,088,855
Remark -
Delayed prices. Updated at 18 Jun 2026 08:15.
Data powered by
View All Events

About Array Technologies

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

Loading Chart...

Please login to view stock data and analysis